Rituximab penetrates full-thickness retina in contrast to tissue plasminogen activator control

Jose S Pulido, Sophie J. Bakri, Tibor Valyi-Nagy, Deepak Shukla

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

PURPOSE: To assess whether intravitreal rituximab 1 mg/0.1 cc penetrates the retina of Dutch-belted rabbits. METHODS: Two right eyes of two rabbits were injected with intravitreal rituximab 1 mg/0.1 mL, and one right eye of one rabbit was injected with intravitreal tissue plasminogen activator (tPA) 12.5 μg/0.1 mL, as a protein control. The three left eyes received no intravitreal injections. The rabbits were killed; the eyes were enucleated and immediately frozen at -80°C. Rituximab was detected using rabbit antihuman IgG (whole molecule) peroxidase conjugated antibody. tPA was detected using an antihuman IgG with a sheep antihuman tPA antibody conjugated with peroxidase. RESULTS: There was staining in all retinal layers of the two eyes injected with intravitreal rituximab, and no staining of the retina in the eye injected with intravitreal tPA. The three control eyes showed no staining in any retinal layer. CONCLUSION: Intravitreal rituximab at a dose of 1 mg/0.1 cc penetrates the retina of Dutch-belted rabbits while the control intravitreal tPA at a dose of 12.5 μg/0.1 cc does not.

Original languageEnglish (US)
Pages (from-to)1071-1073
Number of pages3
JournalRetina
Volume27
Issue number8
DOIs
StatePublished - Oct 2007

Fingerprint

Tissue Plasminogen Activator
Retina
Rabbits
Staining and Labeling
Peroxidase
Immunoglobulin G
Intravitreal Injections
Antibodies
Rituximab
Sheep
Proteins

Keywords

  • Alteplase
  • Eye
  • Intravitreal
  • Penetration
  • Retina
  • Rituxan
  • Rituximab
  • Tissue plasminogen activator

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Rituximab penetrates full-thickness retina in contrast to tissue plasminogen activator control. / Pulido, Jose S; Bakri, Sophie J.; Valyi-Nagy, Tibor; Shukla, Deepak.

In: Retina, Vol. 27, No. 8, 10.2007, p. 1071-1073.

Research output: Contribution to journalArticle

Pulido, Jose S ; Bakri, Sophie J. ; Valyi-Nagy, Tibor ; Shukla, Deepak. / Rituximab penetrates full-thickness retina in contrast to tissue plasminogen activator control. In: Retina. 2007 ; Vol. 27, No. 8. pp. 1071-1073.
@article{693f46956e934034b067c5561abdacd2,
title = "Rituximab penetrates full-thickness retina in contrast to tissue plasminogen activator control",
abstract = "PURPOSE: To assess whether intravitreal rituximab 1 mg/0.1 cc penetrates the retina of Dutch-belted rabbits. METHODS: Two right eyes of two rabbits were injected with intravitreal rituximab 1 mg/0.1 mL, and one right eye of one rabbit was injected with intravitreal tissue plasminogen activator (tPA) 12.5 μg/0.1 mL, as a protein control. The three left eyes received no intravitreal injections. The rabbits were killed; the eyes were enucleated and immediately frozen at -80°C. Rituximab was detected using rabbit antihuman IgG (whole molecule) peroxidase conjugated antibody. tPA was detected using an antihuman IgG with a sheep antihuman tPA antibody conjugated with peroxidase. RESULTS: There was staining in all retinal layers of the two eyes injected with intravitreal rituximab, and no staining of the retina in the eye injected with intravitreal tPA. The three control eyes showed no staining in any retinal layer. CONCLUSION: Intravitreal rituximab at a dose of 1 mg/0.1 cc penetrates the retina of Dutch-belted rabbits while the control intravitreal tPA at a dose of 12.5 μg/0.1 cc does not.",
keywords = "Alteplase, Eye, Intravitreal, Penetration, Retina, Rituxan, Rituximab, Tissue plasminogen activator",
author = "Pulido, {Jose S} and Bakri, {Sophie J.} and Tibor Valyi-Nagy and Deepak Shukla",
year = "2007",
month = "10",
doi = "10.1097/IAE.0b013e31804ac032",
language = "English (US)",
volume = "27",
pages = "1071--1073",
journal = "Retina",
issn = "0275-004X",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Rituximab penetrates full-thickness retina in contrast to tissue plasminogen activator control

AU - Pulido, Jose S

AU - Bakri, Sophie J.

AU - Valyi-Nagy, Tibor

AU - Shukla, Deepak

PY - 2007/10

Y1 - 2007/10

N2 - PURPOSE: To assess whether intravitreal rituximab 1 mg/0.1 cc penetrates the retina of Dutch-belted rabbits. METHODS: Two right eyes of two rabbits were injected with intravitreal rituximab 1 mg/0.1 mL, and one right eye of one rabbit was injected with intravitreal tissue plasminogen activator (tPA) 12.5 μg/0.1 mL, as a protein control. The three left eyes received no intravitreal injections. The rabbits were killed; the eyes were enucleated and immediately frozen at -80°C. Rituximab was detected using rabbit antihuman IgG (whole molecule) peroxidase conjugated antibody. tPA was detected using an antihuman IgG with a sheep antihuman tPA antibody conjugated with peroxidase. RESULTS: There was staining in all retinal layers of the two eyes injected with intravitreal rituximab, and no staining of the retina in the eye injected with intravitreal tPA. The three control eyes showed no staining in any retinal layer. CONCLUSION: Intravitreal rituximab at a dose of 1 mg/0.1 cc penetrates the retina of Dutch-belted rabbits while the control intravitreal tPA at a dose of 12.5 μg/0.1 cc does not.

AB - PURPOSE: To assess whether intravitreal rituximab 1 mg/0.1 cc penetrates the retina of Dutch-belted rabbits. METHODS: Two right eyes of two rabbits were injected with intravitreal rituximab 1 mg/0.1 mL, and one right eye of one rabbit was injected with intravitreal tissue plasminogen activator (tPA) 12.5 μg/0.1 mL, as a protein control. The three left eyes received no intravitreal injections. The rabbits were killed; the eyes were enucleated and immediately frozen at -80°C. Rituximab was detected using rabbit antihuman IgG (whole molecule) peroxidase conjugated antibody. tPA was detected using an antihuman IgG with a sheep antihuman tPA antibody conjugated with peroxidase. RESULTS: There was staining in all retinal layers of the two eyes injected with intravitreal rituximab, and no staining of the retina in the eye injected with intravitreal tPA. The three control eyes showed no staining in any retinal layer. CONCLUSION: Intravitreal rituximab at a dose of 1 mg/0.1 cc penetrates the retina of Dutch-belted rabbits while the control intravitreal tPA at a dose of 12.5 μg/0.1 cc does not.

KW - Alteplase

KW - Eye

KW - Intravitreal

KW - Penetration

KW - Retina

KW - Rituxan

KW - Rituximab

KW - Tissue plasminogen activator

UR - http://www.scopus.com/inward/record.url?scp=37349105294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37349105294&partnerID=8YFLogxK

U2 - 10.1097/IAE.0b013e31804ac032

DO - 10.1097/IAE.0b013e31804ac032

M3 - Article

C2 - 18040247

AN - SCOPUS:37349105294

VL - 27

SP - 1071

EP - 1073

JO - Retina

JF - Retina

SN - 0275-004X

IS - 8

ER -